David A Metcalfe insider trades: Nextgen Healthcare (NXGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | NXGN | ↓ Sell | 32,372 | $20.58 | $666K | Direct | Dec 2, 2022 (1d) |
| Nov 1, 2022 | NXGN | ↓ Sell | 32,372 | $20.00 | $647K | Direct | Nov 2, 2022 (1d) |
| Oct 26, 2022 | NXGN | ↓ Sell | 32,372 | $20.21 | $654K | Direct | Oct 28, 2022 (2d) |
| May 3, 2022 | NXGN | ↓ Sell | 33,838 | $20.00 | $677K | Direct | May 4, 2022 (1d) |
| Apr 25, 2022 | NXGN | ↓ Sell | 33,838 | $20.11 | $681K | Direct | Apr 26, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David A Metcalfe's insider trades
David A Metcalfe is Chief Technology Officer at Nextgen Healthcare (NXGN). Since Apr 25, 2022, David has reported no open-market purchases and 5 sales worth $3.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (19 filings), grants and awards (9 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NXGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.